
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
Hepatitis B test: antibodies to HBeAg (Anti-HBe) in blood
Medical expert of the article
Last reviewed: 06.07.2025
Anti-HB e is normally absent in blood serum.
The appearance of anti-HB e antibodies usually indicates intensive elimination of the hepatitis B virus from the body and minor infection of the patient. These antibodies appear in the acute period and persist for up to 5 years after the infection. In chronic persistent hepatitis, anti-HB e is detected in the patient's blood together with HB s Ag. Seroconversion, i.e. the transition of HB e Ag to anti-HB e in chronic active hepatitis, is often prognostically favorable, but the same seroconversion in severe cirrhotic transformation of the liver does not improve the prognosis.
Blood testing for the presence of anti-HB e is used for the following purposes:
- diagnostics of viral hepatitis B:
- initial stage of the disease;
- acute period of infection;
- early stage of convalescence;
- convalescence;
- late stage of convalescence;
- diagnosis of recent viral hepatitis B;
- Diagnosis of chronic persistent viral hepatitis B.
Criteria for the presence of chronic viral hepatitis B:
- detection of HB s Ag in the blood for more than 6 months;
- continuous or periodic detection of hepatitis B viral DNA in the blood;
- constant or periodic increase in ALT/AST activity in the blood;
- morphological signs of chronic hepatitis in histological examination of liver biopsy.